Nobivac® KC
Nobivac KC provides vaccination against two significant causes of infectious tracheobronchitis (commonly referred to as kennel cough) and is recommended for any dogs that are regularly mixed or kennelled with others (e.g. boarding, dog training etc.). Dogs at risk of this whooping cough-like syndrome benefit from vaccination against this very common and widespread threat.
Presentation
Off-white or cream-coloured lyophilisate and clear colourless solvent for suspension for nasal administration.
Active ingredients
Nobivac KC is a live freeze-dried vaccine.
Per dose of 0.4 ml vaccine reconstituted with diluent:
≥108.0 and ≤109.7 CFU1 of live Bordetella bronchiseptica bacteria strain B-C2
≥103.0 and ≤105.8 TCID502 of live canine parainfluenza virus strain Cornell.
1 Colony Forming Units
2 TCID50= Median Tissue Culture Infective Dose
Target species
Dog
Indications for use
Nobivac KC is indicated:
- For the active immunisation of dogs against Bordetella bronchiseptica and canine parainfluenza virus for periods of increased risk.
- To reduce clinical signs induced by B. bronchiseptica and canine parainfluenza virus.
- To reduce shedding of canine parainfluenza virus.
Packaging
APET-Plastic trays of 5 or 25 single dose vials with diluent available in separate packs.
Legal category
POM-V
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018
